Treatment type

Oral Medicine

Treatments and trials using Oral Medicine. Filter by country, access level, or patient stories.

All countries United States Canada United Kingdom Japan China Australia Switzerland European Union Newest Patient Stories

FDA ApprovedUnited States China

New Pill for Mantle Cell Lymphoma After Prior Treatment

Beqalzi (sonrotoclax) — oral BCL-2 inhibitor for R/R mantle cell lymphoma after ≥2 lines including a BTK inhibitor

FDA accelerated approval on 13 May 2026 for Beqalzi (sonrotoclax) tablets — an oral BCL-2 inhibitor — for adults with relapsed or refractory mantle cell…

This is for adults with relapsed or refractory mantle cell lymphoma who have already had at least two systemic treatments, including a BTK inhibitor, and who…

September 7, 2026

Health Canada/FDA ApprovedUnited States Canada United Kingdom China European Union

New Pill When the Heart Muscle Is Too Thick

Myqorzo (aficamten) for obstructive hypertrophic cardiomyopathy

The US, Europe, the UK and China have labelled aficamten for adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM).

Myqorzo (aficamten) is approved in the United States, Europe, the United Kingdom, China and Canada for adults with symptoms from obstructive hypertrophic…

September 3, 2026